Professor, Gynecology Oncology
Director, Gynecology Oncology
Gynecologic Oncology Program
Area of Interest
My clinical interests focus on gynecologic oncology.
My research focuses on understanding the interactions between cell signaling pathways implicated in endometrial cancer pathogenesis as a means to target therapy for this disease. In this pursuit, I have investigated many novel targeted therapies for the treatment of endometrial cancer, including mTOR inhibitors, arsenic, a human monoclonal antibody to the insulin growth factor-1 receptor (IGF-1R), soy, genistein and most recently, metformin.
I am also interested in the impact that obesity has on endometrial cancer development and progression which may invariably dictate different treatment options for this particularly high-risk patient population. In addition, I have a clinical trial underway which is a microarray-based endeavor to correlate gene expression patterns with clinical outcomes and parameters in endometrial cancer, including obesity, lymph node status and recurrence risk.
Awards and Honors
- Elected to Board of Directors, Society of Gynecologic Oncology, 2023
- Innovation Award, Society of Gynecologic Oncology, Annual Meeting on Women’s Cancer, Tampa, Florida, 2023
- Elected co-chair of the National Cancer Institute Gynecologic Cancers Steering Committee’s Uterine Task Force, 2022
- Society of Gynecologic Oncologists, Moderator for Translational Research Focused Plenary, 2010
- Society of Gynecologic Investigation, Moderator for Gynecological Oncology Oral Presentations, 2010
- Mid-Atlantic Gynecologic Oncology Society, Secretary-Treasurer, 2010
- Roadmap Multidisciplinary Clinical Research Career Development K12 Scholar, 2007-2010
- University of North Carolina at Chapel Hill, University Cancer Research Fund (UCRF) Award, 2008-2010
News and Stories
UNC Lineberger faculty, trainees present research, receive honors at Society of Gynecologic Oncology annual meeting
UNC Lineberger was well represented at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer in Tampa, Florida.
Leading investigators offer ‘highly scientific, but patient-focused’ talks on women’s cancers at symposium
UNC Lineberger’s 46th annual Scientific Symposium brought together more than 350 people in person and virtually to hear talks on the latest research on women’s cancers.
White House turns to UNC Lineberger for cancer prevention, smoking cessation insights
The White House Chief Science and Technology Advisor Arati Prabhakar, MS, PhD, visited Chapel Hill to discuss the fight against cancer at the UNC Lineberger Comprehensive Cancer Center.
Bae-Jump elected co-chair of NCI uterine task force
Victoria Bae-Jump, MD, PhD, has been elected co-chair of the National Cancer Institute Gynecologic Cancers Steering Committee’s Uterine Task Force.